Post by Monte Rosa Therapeutics

Excellent article from Bloomberg News on the growing momentum behind molecular glue degraders and their potential to transform the treatment landscape across multiple therapeutic areas. Thank you to Robert Langreth for the insightful coverage and including Monte Rosa among the companies advancing this modality. As pioneers in molecular glue degrader discovery and development, we remain focused on unlocking new therapeutic possibilities against disease-driving targets that have long been considered "undruggable.” Read the article: https://bloom.bg/4a42x66